NY Times article highlights Abeta research of Cure Alzheimer Fund Researchers

Posted December 14, 2010

Three members of Cure Alzheimer’s Fund Research Consortium – Dr. David Holtzman, Dr. Robert Malinow and Dr. Sam Gandy – are featured in a New York Times article highlighting their groundbreaking work on amyloid beta protein and its role in Alzheimer’s. Veteran reporter Gina Kolata discusses how their important research is part of “a wave of unexpected findings” leading to new insights about the disease and potential new drug targets to attack Alzheimer’s.

Dr. Holtzman put it best in the article how these new findings are offering real hope to the millions of people living with this devastating disease and their families. “We have a richer view of the genesis of Alzheimer’s disease as well as new directions for research, prevention and treatment.”

Read the full article here: